RSS

drug prices

Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautious of fierce generic competition… more

News

The recently announced ‘Biosimilar Action Plan’ (BAP) from the US Food and Drug Administration (FDA) is another move by the regulatory body to achieve cost-effective pricing, according to an analyst at data and analytics company, GlobalData. more

News

Commissioner of the US Food and Drug Administration (FDA), Dr Scott Gottlieb, has released a statement highlighting new efforts to raise awareness of situations where drug makers may be ‘pursuing gaming tactics to delay generic competition’ more

News

Five organisations that represent more than 450 hospitals in the US are working together to develop a not-for-profit generic drug company to make more essential medications more widely available and less expensive. more

News

Patients suffering with cancer and severe mental illness are being hit by drug shortages, costing the NHS £180 million in half a year, according a report published by The Times. more

News

A new government ruling, allowing the erectile dysfunction (ED) drug Sildenafil to be sold without a prescription, could mean drug prices fall further. more

News

The US Food and Drug Administration (FDA) has started taking actions on its plan to tackle drug competition within the field of prescription drugs and facilitation of lower-cost alternatives. more

News

The Food and Drug Administration (FDA), under new commissioner Scott Gottlieb, will be taking more of an active role in the issues surrounding drug prices, according to various US news sources. more

News